anhidrázgátlókat

Anhidrázgátlók is the Hungarian term for carbonic anhydrase inhibitors. These are a class of drugs that inhibit the enzyme carbonic anhydrase, which plays a crucial role in various physiological processes, including the regulation of pH and fluid balance.

The primary medical application of anhidrázgátlók is in the treatment of glaucoma. By inhibiting carbonic anhydrase in the ciliary body of the eye, these drugs reduce the production of aqueous humor, thereby lowering intraocular pressure. This effect is beneficial for patients suffering from open-angle glaucoma and certain types of acute angle-closure glaucoma.

Beyond ophthalmology, anhidrázgátlók are also used as diuretics. They promote the excretion of sodium, potassium, and bicarbonate ions, leading to increased urine production and a reduction in fluid volume. This diuretic effect makes them useful in managing edema associated with conditions like heart failure and epilepsy, where they can also help to prevent seizures.

Commonly prescribed anhidrázgátlók include acetazolamide, dorzolamide, and brinzolamide. While generally well-tolerated, potential side effects can include tingling sensations, fatigue, nausea, and metabolic acidosis. Their use requires careful medical supervision due to potential interactions with other medications and contraindications in certain patient populations.